Dave Brubeck, Jazz Icon, Dies at 91

By Kevin O'Donnell

12/05/2012 at 01:30 PM EST

Dave Brubeck, the pianist, composer and leader of the iconic Dave Brubeck Quartet, died Wednesday at age 91 in Connecticut, according to the AP. The cause was heart failure.

Brubeck, whose music helped define the style of West Coast Jazz in the '50s, is best known for the 1959 classic "Take 5," which was written by collaborator Paul Desmond and featured on the album Time Out. To date, it remains one of the top-selling jazz records of all time.

Brubeck wasn't just a music icon – he was also a patriot. Born in California in 1920, he was drafted into the army to serve in Europe during World War II. Upon returning home in 1946, music teacher Darius Milhaud encouraged him to pursue music.

"He told me if I didn't stick to jazz, I'd be working out of my own field and not taking advantage of my American heritage," Brubeck told TIME in a 1954 cover story.

That heritage was cemented in 2009, when Brubeck was inducted as a Kennedy Center Honoree for his lifetime of contributions to American culture – one of the nation's most esteemed honors.

Of his love for music, Brubeck told TIME, "When I get inspired, I'm the happiest guy in the world."

Brubeck is survived by his wife Iola, sons Darius, Dan, Chris, and Matthew, daughter Cathy, and two generations of grandchildren.

Read More..

Longer tamoxifen use cuts breast cancer deaths

Breast cancer patients taking the drug tamoxifen can cut their chances of having the disease come back or kill them if they stay on the pills for 10 years instead of five years as doctors recommend now, a major study finds.

The results could change treatment, especially for younger women. The findings are a surprise because earlier research suggested that taking the hormone-blocking drug for longer than five years didn't help and might even be harmful.

In the new study, researchers found that women who took tamoxifen for 10 years lowered their risk of a recurrence by 25 percent and of dying of breast cancer by 29 percent compared to those who took the pills for just five years.

In absolute terms, continuing on tamoxifen kept three additional women out of every 100 from dying of breast cancer within five to 14 years from when their disease was diagnosed. When added to the benefit from the first five years of use, a decade of tamoxifen can cut breast cancer mortality in half during the second decade after diagnosis, researchers estimate.

Some women balk at taking a preventive drug for so long, but for those at high risk of a recurrence, "this will be a convincer that they should continue," said Dr. Peter Ravdin, director of the breast cancer program at the UT Health Science Center in San Antonio.

He reviewed results of the study, which was being presented Wednesday at a breast cancer conference in San Antonio and published by the British medical journal Lancet.

About 50,000 of the roughly 230,000 new cases of breast cancer in the United States each year occur in women before menopause. Most breast cancers are fueled by estrogen, and hormone blockers are known to cut the risk of recurrence in such cases.

Tamoxifen long was the top choice, but newer drugs called aromatase inhibitors — sold as Arimidex, Femara, Aromasin and in generic form — do the job with less risk of causing uterine cancer and other problems.

But the newer drugs don't work well before menopause. Even some women past menopause choose tamoxifen over the newer drugs, which cost more and have different side effects such as joint pain, bone loss and sexual problems.

The new study aimed to see whether over a very long time, longer treatment with tamoxifen could help.

Dr. Christina Davies of the University of Oxford in England and other researchers assigned 6,846 women who already had taken tamoxifen for five years to either stay on it or take dummy pills for another five years.

Researchers saw little difference in the groups five to nine years after diagnosis. But beyond that time, 15 percent of women who had stopped taking tamoxifen after five years had died of breast cancer versus 12 percent of those who took it for 10 years. Cancer had returned in 25 percent of women on the shorter treatment versus 21 percent of those treated longer.

Tamoxifen had some troubling side effects: Longer use nearly doubled the risk of endometrial cancer. But it rarely proved fatal, and there was no increased risk among premenopausal women in the study — the very group tamoxifen helps most.

"Overall the benefits of extended tamoxifen seemed to outweigh the risks substantially," Dr. Trevor Powles of the Cancer Centre London wrote in an editorial published with the study.

The study was sponsored by cancer research organizations in Britain and Europe, the United States Army, and AstraZeneca PLC, which makes Nolvadex, a brand of tamoxifen, which also is sold as a generic for 10 to 50 cents a day. Brand-name versions of the newer hormone blockers, aromatase inhibitors, are $300 or more per month, but generics are available for much less.

The results pose a quandary for breast cancer patients past menopause and those who become menopausal because of their treatment — the vast majority of cases. Previous studies found that starting on one of the newer hormone blockers led to fewer relapses than initial treatment with tamoxifen did.

Another study found that switching to one of the new drugs after five years of tamoxifen cut the risk of breast cancer recurrence nearly in half — more than what was seen in the new study of 10 years of tamoxifen.

"For postmenopausal women, the data still remain much stronger at this point for a switch to an aromatase inhibitor," said that study's leader, Dr. Paul Goss of Massachusetts General Hospital. He has been a paid speaker for a company that makes one of those drugs.

Women in his study have not been followed long enough to see whether switching cuts deaths from breast cancer, as 10 years of tamoxifen did. Results are expected in about a year.

The cancer conference is sponsored by the American Association for Cancer Research, Baylor College of Medicine and the UT Health Science Center.

___

Marilynn Marchione can be followed at http://twitter.com/MMarchioneAP

Read More..

Wall Street rebounds as banks, Travelers offset Apple

NEW YORK (Reuters) - Stocks advanced in a choppy session on Wednesday as a rally in bank shares and The Travelers, a Dow component, overshadowed Apple's unexpected drop and weakness in the technology sector.

Equities staged a turnaround in the face of a drop in Apple , the largest U.S. company by market capitalization and a big weight in both the S&P 500 and the Nasdaq. Apple's stock fell 4.2 percent to $551.74, after dropping as low as $545.56.

Market participants cited a host of reasons for the slide in the iPad maker's stock, including a consultant's report about the company losing share in the tablet market and reports that margin requirements had been raised by at least one clearing firm.

The S&P 500 reversed course after briefly falling below the 1,400 level, seen as a key support point over the past two weeks.

"There's still psychological interest in buying the market," said John Brady, managing director at R.J. O'Brien & Associates in Chicago.

"The S&P hit the 1,400 level so we find again ‘dip buyers' there. They strongly believe a deal (on the fiscal cliff) is going to get done, and that's really the trade."

Investors have been reluctant to take big positions as lawmakers continue to negotiate a deal to avoid a series of mandatory spending cuts and tax increases effective in early January - known as the "fiscal cliff" - that could push the U.S. economy into recession next year.

President Barack Obama told the Business Roundtable, a group of chief executives, that a "fiscal cliff" deal was possible within about a week if Republicans acknowledged the need to raise taxes on the wealthiest Americans.

For several weeks, the market has reacted quickly to often-conflicting headlines out of Washington about budget negotiations, prompting investors to be cautious.

The Dow Jones industrial average <.dji> gained 123.74 points, or 0.96 percent, to 13,075.52. The Standard & Poor's 500 Index <.spx> rose 6.92 points, or 0.49 percent, to 1,411.97. But the Nasdaq Composite Index <.ixic> dropped 9.51 points, or 0.32 percent, to 2,987.17.

Banking shares were the best performers, led by a 6.4 percent climb in Citigroup to $36.48 after the company said it will cut 11,000 jobs worldwide, or about 4 percent of its workforce. The KBW Bank Index <.bkx> rose 2.1 percent.

Bank of America shares shot up 5.1 percent to $10.40 after hitting a new 52-week high at $10.44.

Shares of Freeport-McMoRan Copper & Gold Inc slumped 13.6 percent to $33.07. The company said it is acquiring Plains Exploration & Production Co and McMoRan Exploration Co in two separate deals for $9 billion in cash and stock in a major expansion into energy.

But shares of McMoRan Exploration soared 82.7 percent to $15.46 and Plains Exploration & Production shares surged 25.5 percent to $45.23.

Shares of The Travelers Cos Inc rose 4.7 percent to $73.81 and ranked as the Dow's top gainer after the property and casualty insurance company said its preliminary estimate of net losses from Superstorm Sandy was about $650 million after tax.

Economic data from payrolls processor ADP showed U.S. private-sector hiring took a hit in November due to the impact of Superstorm Sandy, which ravaged consumers and businesses in the Northeastern United States, but the huge services sector kept expanding albeit at a modest pace, according to the Institute for Supply Management.

(Additional reporting by Rodrigo Campos; Editing by Jan Paschal)

Read More..

5 Nations Summon Israeli Envoys to Protest Settlement Plans

JERUSALEM — Britain, France, Spain, Sweden and Denmark summoned the Israeli ambassadors to their countries on Monday to protest Israel’s plans for increased settlement construction, an unusually sharp diplomatic step that reflected the growing frustration abroad with Israel’s policies on the Palestinian issue.

After the General Assembly voted overwhelmingly last week to upgrade the status of the Palestinians at the United Nations, Israel announced plans for 3,000 more housing units in contested areas of East Jerusalem and around the West Bank.

Israel raised particular alarms with its decision to continue planning and zoning work for the development of a contentious area known as E1, a project vehemently opposed internationally because it would partially separate the northern and southern West Bank, harming the prospects of a contiguous Palestinian state in that territory.

The move raised questions in Israel about whether the country’s leaders were putting domestic political interests ahead of its foreign relations, with Israeli elections scheduled for late January.

“Bibi had to do something” in response to the United Nations vote, said Prof. Shmuel Sandler of the Begin-Sadat Center for Strategic Studies at Bar-Ilan Universiy, referring to the prime minister of Israel, Benjamin Netanyahu, by his nickname, “first because he is Bibi and second because of the elections.”

Mr. Sandler said that Mr. Netanyahu, a conservative, was making the mistake of competing against those farther to the right, adding, “But I don’t think he expected such a reaction” internationally.

Yet Israel remained defiant. The prime minister’s office issued a statement on Monday, saying, “Israel will continue to stand for its essential interests, even in the face of international pressure, and there will be no change in the decision it has taken.”

A press officer for United Nations Secretary General Ban Ki-moon said in a statement on Sunday that construction in E1 “would represent an almost fatal blow to remaining chances of securing a two-state solution.”

European countries long opposed to Israeli settlement construction went beyond their usual statements of condemnation. The countries that called in the Israeli ambassadors “expressed their strong protests about the announced settlement plans,” said Yigal Palmor, the spokesman for the Israeli Foreign Ministry.

Mr. Palmor said that the Israeli ambassadors told their hosts that Israel had been warning for months that the Palestinian bid at the United Nations would not go unanswered and that it would have implications.

Israel has described the bid as a unilateral Palestinian step that violates previous signed agreements. The Palestinians have long refused to negotiate with Israel without a halt in settlement construction.

France, Spain, Sweden and Denmark voted for the Palestinian upgrade, while Britain abstained. Although Israel had expected the resolution to pass, officials here expressed disappointment over the lack of support from several friendly European nations. Israel was particularly surprised by Germany’s decision to abstain in the vote, having expected Germany to go with Israel.

Prime Minister Benjamin Netanyahu is scheduled to visit Germany this week. Despite the so-called special relationship between Israel and Germany, Chancellor Angela Merkel has not minced words about her opposition to Israeli settlement construction in the past.

Philippe Lalliot, a spokesman for the French Foreign Ministry, said in a statement on Monday, “Settlement activity is illegal under international law, hurts the confidence necessary for a return to dialogue and constitutes an obstacle to a just peace founded on the two-state solution.”

The British Foreign Office said that it deplored the Israeli settlement plans and that it had called on the Israeli government to reverse the decision.

But Israeli officials denied that the government’s policies were isolating Israel.

“It is well known that Europe and Israel have a different approach on settlements,” said one Israeli official, speaking on the condition of anonymity. “There is nothing new here. If European countries would have behaved differently in their vote at the United Nations last week,” he continued, “we may have reacted differently.”

Analysts here said that after showing strong support for Israel during its military campaign last month against Hamas, the Islamic militant group that controls Gaza, European countries had felt the need to bolster the more moderate Palestinian wing led by President Mahmoud Abbas in its United Nations bid.

At the weekly cabinet meeting on Sunday, Mr. Netanyahu said, “Today we are building and we will continue to build in Jerusalem and in all areas that are on the map of the strategic interests of the State of Israel.”

But beyond the tit-for-tat measures set off by the United Nations vote, analysts pointed to a trend of deteriorating relations between Israel and Europe in particular.

“That is because the top-level people making decisions here in recent years are completely insular and out of touch with the rest of the world, especially regarding the Palestinians and the settlements,” said Mark Heller, a foreign-policy analyst at the Institute for National Security Studies at Tel Aviv University. “Self-righteousness may be good for domestic politics,” he said, “but it is not a policy.”

At the United Nations General Assembly on Thursday, 138 nations voted in favor of upgrading the status of the Palestinians and 41 abstained. The nine that voted against it were Israel, the United States, Canada, the Czech Republic, the Marshall Islands, Micronesia, Nauru, Panama and Palau.

Scott Sayare contributed reporting from Paris.

Read More..

Is the iPad Mini as Good as the iPad?

The iPad Mini‘s screen doesn’t have the same “resolutionary” Retina display as its bigger brother, but don’t worry: the Apple snobs appear to have gotten over that. After spending time with his new baby-tablet, The New York Times‘s Nick Bilton gave in, calling the gadget his new “Desert Island Device.” (It replaced his iPhone, by the way.) The inferior screen had worried Bilton like it had others, but no longer: ”I used it for two weeks and my concerns about the screen’s quality are completely irrelevant.” It’s not that Bilton prefers the “fuzzy” screen, as he called it. But the portability of the lightweight Mini outweighs that for him, making this tablet, in his opinion, really the best tablet Apple has ever made.

RELATED: Prepare for an iPad Mini This Month

Considering all the fawning over the Retina display on the iPad proper, it’s pretty amazing to see reviewers toss that upgrade for something that Steve Jobs forbid the company to create. Bilton’s not the only one to prefer the new cousin, even if it is technically worse. Noted Apple-phile Jonathan Gruber said he hadn’t touched the fourth-generation iPad that Apple released this year as well “I’ve gone small and fuzzy,” he wrote. When the Retina display first came out, Gruber called it “pure joy” for his “dream iPad.” But a funny thing happened on the way out of the hype cycle: Apple put out something the masses were supposed to like more than the techies, and that just made everyone like it even more. Call it a holiday miracle, but the Apple snobs may be snobs no more.

Gadgets News Headlines – Yahoo! News

Read More..

Holly Madison: I Want Six Kids

Mom & Babies
Celebrity Baby Blog

12/03/2012 at 01:00 PM ET

AKM-GSI

With a daughter on the way in March, Holly Madison switched it up by wearing blue to Saturday’s Animal Foundation Happy Anniversary Hour, held at the House of Blues Foundation Room in Las Vegas.

It was a welcome change for the former reality star, who admits she was hit with “a tide” of pink product upon announcing the sex of her baby. Not that it’s unwelcome, of course — Madison has been patiently awaiting the bundle of joy she’s now expecting with boyfriend Pasquale Rotella.

“We knew we wanted to try to have kids, but probably next year,” she tells Las Vegas Weekly. “I don’t know why this is, maybe because I am 33, but I didn’t think it would be that easy for me to get pregnant. But it was.”

And if Madison has it her way, it will continue to be. “I want six kids,” she says. “We’ll see how it goes, but I want a big family.”

Read More..

CDC says US flu season starts early, could be bad

NEW YORK (AP) — Flu season in the U.S. is off to its earliest start in nearly a decade — and it could be a bad one.

Health officials on Monday said suspected flu cases have jumped in five Southern states, and the primary strain circulating tends to make people sicker than other types. It is particularly hard on the elderly.

"It looks like it's shaping up to be a bad flu season, but only time will tell," said Dr. Thomas Frieden, director of the Centers for Disease Control and Prevention.

The good news is that the nation seems fairly well prepared, Frieden said. More than a third of Americans have been vaccinated, and the vaccine formulated for this year is well-matched to the strains of the virus seen so far, CDC officials said.

Higher-than-normal reports of flu have come in from Alabama, Louisiana, Mississippi, Tennessee and Texas. An uptick like this usually doesn't happen until after Christmas. Flu-related hospitalizations are also rising earlier than usual, and there have already been two deaths in children.

Hospitals and urgent care centers in northern Alabama have been bustling. "Fortunately, the cases have been relatively mild," said Dr. Henry Wang, an emergency medicine physician at the University of Alabama at Birmingham.

Parts of Georgia have seen a boom in traffic, too. It's not clear why the flu is showing up so early, or how long it will stay.

"My advice is: Get the vaccine now," said Dr. James Steinberg, an Emory University infectious diseases specialist in Atlanta.

The last time a conventional flu season started this early was the winter of 2003-04, which proved to be one of the most lethal seasons in the past 35 years, with more than 48,000 deaths. The dominant type of flu back then was the same one seen this year.

One key difference between then and now: In 2003-04, the vaccine was poorly matched to the predominant flu strain. Also, there's more vaccine now, and vaccination rates have risen for the general public and for key groups such as pregnant women and health care workers.

An estimated 112 million Americans have been vaccinated so far, the CDC said. Flu vaccinations are recommended for everyone 6 months or older.

On average, about 24,000 Americans die each flu season, according to the CDC.

Flu usually peaks in midwinter. Symptoms can include fever, cough, runny nose, head and body aches and fatigue. Some people also suffer vomiting and diarrhea, and some develop pneumonia or other severe complications.

A strain of swine flu that hit in 2009 caused a wave of cases in the spring and then again in the early fall. But that was considered a unique type of flu, distinct from the conventional strains that circulate every year.

__

Online:

CDC: http://www.cdc.gov/flu/weekly

Read More..

Wall Street little changed before next "cliff" signal

NEW YORK (Reuters) - Stocks were little changed on Tuesday as the market awaited developments in negotiations in Washington to avert a "fiscal cliff" that could push the U.S. economy into recession.

Republicans in Congress proposed steep spending cuts to bring down the budget deficit on Monday but gave no ground on President Barack Obama's call to raise taxes on the wealthiest Americans, and the proposal was quickly dismissed by the White House.

The market has been subject to swings in reaction to the proposals floated so far by politicians. Still, many investors expect the two sides to come up with a deal before the year-end deadline, which could trigger a rally in equities.

"Investors everywhere are focused on what is happening here related to the fiscal cliff and the risk that nothing will happen," said Gail Dudack, Chief Investment Strategist, Dudack Research Group in New York.

"From what I have seen, there is a consensus that something will happen. Maybe if it is not ideal, something will happen."

Differences within the Republican Party over how to engage with the Democrats came to the fore on Tuesday as one senator opposed to raising taxes lashed out at House Speaker and fellow Republican John Boehner for proposing to increase revenue by closing some tax loopholes.

Despite the sudden moves in the market, a measure of investor anxiety has held surprisingly flat.

The CBOE volatility index <.vix>, a gauge of market anxiety, was at 17 but has not traded above 20 since July following its 2012 high near 28 hit in June. The VIX's 10-day Average True Range, an internal volatility measure, is at its lowest since early 2007.

Obama will meet with U.S. governors at the White House on Tuesday to talk about the fiscal cliff, a $600 billion package of tax hikes and federal spending cuts that would begin January 1.

The president is also expected to talk about the fiscal cliff during an interview scheduled for 12:30 p.m. (1730 GMT) on Bloomberg TV.

Coach became the latest company to advance the date of its next dividend payment. Expectations of higher taxes on dividends kicking in in 2013 have pushed many companies to pay special dividends this year or advance their next pay-back to investors. Shares of the upscale leather-goods maker shed 1.6 percent to $57.25.

The Dow Jones industrial average <.dji> rose 27.92 points, or 0.22 percent, to 12,993.52. The S&P 500 <.spx> edged up 0.44 points, or 0.03 percent, to 1,409.90. The Nasdaq Composite <.ixic> fell 4.44 points, or 0.15 percent, to 2,997.76.

Darden Restaurants Inc plunged 10.1 percent to $47.14 as the worst performer on the S&P 500 after warning its latest quarter would miss expectations after unsuccessful promotions led to a decline in sales at its Olive Garden, Red Lobster and LongHorn Steakhouse chains.

In contrast, Big Lots Inc jumped 8 percent to $30.28 after the close-out retailer posted a smaller-than-expected loss and boosted its full-year adjusted earnings forecast.

Toll Brothers shares advanced 0.3 percent to $32.53 after the largest U.S. luxury homebuilder reported a higher quarterly profit and said new orders rose sharply.

MetroPCS Communications shares dropped 6.5 percent to $10.07 after Sprint Nextel appeared unlikely to make a counter-offer for the wireless service provider.

Shares of Pep Boys-Manny Moe and Jack slumped 12.5 percent at $9.34 a day after the release of the auto parts retailer's results.

(Reporting by Chuck Mikolajczak; Editing by Kenneth Barry)

Read More..

David Oliver Relin, Co-Author of ‘Three Cups of Tea,’ Dies at 49

David Oliver Relin, a journalist and adventurer who achieved acclaim as co-author of the best seller “Three Cups of Tea” (2006) and then suffered emotionally and financially as basic facts in the book were called into question, died Nov. 15 in Multnomah County, Ore. He was 49.

David Oliver Relin was a co-author of “Three Cups of Tea.”

Some readers questioned details in the best-selling book, "Three Cups of Tea."

His family said Mr. Relin “suffered from depression” and took his own life. The family, speaking through Mr. Relin’s agent, Jin Auh, was unwilling to give further details, but said a police statement would be released this week.

In the 1990s, Mr. Relin established himself as a journalist with an interest in telling “humanitarian” stories about people in need in articles about child soldiers and about his travels in Vietnam.

“He felt his causes passionately,” said Lee Kravitz, the former editor of Parade who hired Mr. Relin at various magazines over the years. “He especially cared about young people. I always assigned him to stories that would inspire people to take action to improve their lives.”

So it made sense when Viking books tapped him to write a book about Greg Mortenson, a mountain climber who had an inspiring story about building schools in Pakistan and Afghanistan.

Elizabeth Kaplan, the agent for the book, acknowledged that the relationship between the two men was difficult from the start. Mr. Mortenson, who was traveling to remote areas, could be hard to track down, and Mr. Relin spoke publicly about how Mr. Mortenson should not have been named a co-author. Still, the book was a huge success, selling more than four million copies.

Some readers, however, found details of the heartwarming tale suspicious. In 2011, the CBS News program “60 Minutes” and the best-selling author Jon Krakauer in an e-book called “Three Cups of Deceit” questioned major points in the book. This included a crucial opening anecdote about Mr. Mortenson’s being rescued by the townspeople of Korphe, Pakistan, after stumbling down a mountain when he was dehydrated and exhausted. It was their care and concern, the book said, that inspired Mr. Mortenson to build schools.

The reports also said some of the schools that Mr. Mortenson’s charity, the Central Asia Institute, said it had established either did not exist or were built by others. There were also charges that the institute had been mismanaging funds and that a substantial portion of the money it raised had been used to promote the book, not for schools.

Mr. Mortenson acknowledged that some of the details in the book were wrong. Mr. Relin did not speak publicly about the charges, but he hired a lawyer to defend himself in a federal lawsuit that accused the authors and the publisher of defrauding readers. The suit was dismissed this year.

In April, the Montana Attorney General’s office announced that Mr. Mortenson had agreed to repay the charity more than $1 million in travel and other expenses used to promote the book, including “inappropriate personal charges.”

David Oliver Relin was born on Dec. 12, 1962, in Rochester to Lloyd and Marjorie Relin. His father died when he was young. Mr. Relin graduated from Vassar College in 1985, and was later awarded a fellowship at the Iowa Writers’ Workshop.

In addition to his mother, he is survived by his wife, Dawn; his stepfather, Cary Ratcliff; and his sisters Rachel Relin and Jennifer Cherelin.

Mr. Relin had completed a new book on two doctors working to cure cataract-related blindness in the developing world. It is scheduled for publication by Random House in spring 2013.

Read More..

Nokia Siemens to sell optical networks unit

FRANKFURT (Reuters) – Mobile telecoms equipment joint venture Nokia Siemens Networks, which is focusing on its core business, is to sell its optical fiber unit to Marlin Equity Partners for an undisclosed sum.

Up to 1,900 employees, mainly in Germany and Portugal, will be transferred to the new company, NSN said on Monday.

The company, owned by Nokia and Siemens, has sold a number of product lines since it last year announced plans to divest non-core assets and cut 17,000 jobs, nearly a quarter of its total workforce.

Nordea Markets analyst Sami Sarkamies said he expected more divestments after the optical unit deal. This disposal was a small surprise, he said, because NSN needed some optical technology – where data is transmitted by pulses of light – for its main mobile broadband business.

The move may hint the company is preparing itself for further consolidation in the sector by cutting overlaps with other players, Sarkamies said.

The telecom equipment market is going through rough times with stiff competition. French Alcatel-Lucent is also cutting costs.

($ 1 = 0.7689 euro)

(Reporting by Harro ten Wold; Editing by Greg Mahlich and Dan Lalor)

Tech News Headlines – Yahoo! News

Read More..